Mitochondria can lose power like batteries, but they can potentially be regenerated—a promising development than can be used ...
This valuable study presents an analysis of the gene regulatory networks that contribute to tumour heterogeneity and tumor plasticity in Ewing sarcoma, with key implications for other fusion-driven ...
AZoLifeSciences on MSN
Engineered Gut Bacteria With MiRNA Nanoparticles To Reverse IBD
Biomimetic nanoparticles delivering microRNA to gut bacteria enhance protective metabolites, repair intestinal barriers, and ...
Bank of America Leveraged Finance Conference December 2, 2025 8:10 AM ESTCompany ParticipantsErin Banyas - Head of ...
A Northwestern Medicine study published in the Journal of Clinical Investigation has uncovered a connection between a ...
Spatial RNA medicine combines transcriptomics and RNA therapeutics, mapping gene expression in tissues to enhance precision ...
News-Medical.Net on MSN
Experimental RNA drug shows promise for repairing DNA and healing tissue damage
Cedars-Sinai scientists have developed an experimental drug that repairs DNA and serves as a prototype for a new class of medications that fix tissue damage caused by heart attack, inflammatory ...
This study presents a large, systematically curated catalog of non-canonical open reading frames (ncORFs) in human and mouse by reanalyzing nearly 400 Ribo-seq datasets using a standardized pipeline; ...
When a cell receives a message from outside, it generates a molecule called cyclic AMP (cAMP) to relay this message. To ...
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced changes to its Board of Directors, including the departure of two directors and the appointment of ...
Iron (Fe) is an essential micronutrient for the healthy growth of plants, including many staple crops like rice. Its deficiency remains a common agricultural problem that slashes crop yields, as it ...
ARWR READ THE FULL ARWR RESEARCH REPORT Business Update Multiple Data Readouts Ahead in 2026 Following the recent approval of REDEMPLO ® for the treatment of patients with familial chylomicronemia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results